Anti-PSA Antibody
Prostate Cancer Screening
Development/CommercialAntibody development for improved assays
Key Facts
Indication
Prostate Cancer Screening
Phase
Development/Commercial
Status
Antibody development for improved assays
Company
About Bioventix
Bioventix is a leading developer of high-affinity sheep monoclonal antibodies, primarily serving the global in vitro diagnostics (IVD) market. Its core expertise lies in creating antibodies for demanding diagnostic assays, with its anti-vitamin D antibody, VITROS® Immunodiagnostic Products 25-OH Vitamin D Total assay, being a major commercial success licensed to Ortho Clinical Diagnostics. The company operates a capital-light, high-margin business model focused on R&D, licensing, and royalty generation from its antibody intellectual property.
View full company profile